Compare
Eastman Chemical Co vs DuPont de Nemours, Inc. vs Albemarle Corp vs Avient Corp
| Latest fiscal year | Eastman Chemical Co EMN | DuPont de Nemours, Inc. DD | Albemarle Corp ALB | Avient Corp AVNT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $8.75B | $6.85B | $5.14B | $3.26B |
| Revenue growth (YoY) | -6.7% | +1.9% | -4.4% | +0.6% |
| Gross margin | 21.1% | n/a | 13.0% | 31.2% |
| Operating margin | n/a | n/a | -7.1% | 6.2% |
| Net margin | 5.4% | -11.4% | -9.9% | 2.5% |
| Net income | $474.00M | -$779.00M | -$510.63M | $81.90M |
| EPS (Diluted) | $4.10 | -$1.86 | -$5.76 | $0.89 |
| Operating cash flow | $970.00M | $560.00M | $1.28B | $301.60M |
| Free cash flow | $424.00M | $227.00M | $692.47M | $195.00M |
| Cash & equivalents | $566.00M | $715.00M | n/a | n/a |
| Total assets | $14.86B | $21.57B | $16.37B | $6.03B |
| Total liabilities | $8.82B | $7.47B | n/a | n/a |
| Shareholders' equity | $5.96B | $14.10B | $9.78B | $2.37B |
| Return on year-end equity | 8.0% | -5.5% | -5.2% | 3.4% |
| Shares outstanding | 223.94M | n/a | 117.72M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Eastman Chemical Co | DuPont de Nemours, Inc. | Albemarle Corp | Avient Corp |
|---|---|---|---|---|
| Latest | $8.75B Ended 2025-12-31 | $6.85B Ended 2025-12-31 | $5.14B Ended 2025-12-31 | $3.26B Ended 2025-12-31 |
| 1 year earlier | $9.38B Ended 2024-12-31 | $6.72B Ended 2024-12-31 | $5.38B Ended 2024-12-31 | $3.24B Ended 2024-12-31 |
| 2 years earlier | $9.21B Ended 2023-12-31 | $6.61B Ended 2023-12-31 | $9.62B Ended 2023-12-31 | $3.14B Ended 2023-12-31 |
| 3 years earlier | $10.58B Ended 2022-12-31 | $13.02B Ended 2022-12-31 | $7.32B Ended 2022-12-31 | $3.40B Ended 2022-12-31 |
| 4 years earlier | $10.48B Ended 2021-12-31 | $12.57B Ended 2021-12-31 | $3.33B Ended 2021-12-31 | $3.32B Ended 2021-12-31 |